Critic At Large Articles - science publishing, disease/medicine and policy

By Lisa A. Haile and Kimberly K. Egan | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

By Richard Smith | April 1, 2012

Will traditional scientific journals follow newspapers into oblivion?

By Bonnie M. Marshall and Stuart B. Levy | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

By Richard P. Sloan | August 1, 2011

Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.

By Michael K. Gusmano | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

By Nicholas P. Restifo and Megan Bachinski | April 11, 2011

For cancer patients, close is not good enough.

The Scientist